Results for tag: "Familial Adenomatous Polyposis Drug"

Familial Adenomatous Polyposis (FAP) is a rare genetic disorder that causes the formation of numerous polyps in the colon. These polyps can become cancerous if left untreated. As such, drugs used to treat FAP are important in the treatment of colon cancer. These drugs are typically targeted therapies, which are designed to specifically target the genetic mutation that causes FAP. Commonly used drugs include bevacizumab, cetuximab, and panitumumab. These drugs are used in combination with other treatments such as chemotherapy and radiation therapy. The Familial Adenomatous Polyposis Drug market is a small but growing market. It is driven by the increasing prevalence of FAP and the need for effective treatments. The market is expected to grow in the coming years as new treatments are developed and approved. Some companies in the market include Roche, Merck, Pfizer, and Bristol-Myers Squibb. These companies are involved in the development and marketing of drugs used to treat FAP. Show Less Read more